Cancer risk in MLH1, MSH2 and MSH6 mutation carriers; different risk profiles may influence clinical management
-
* Corresponding author: Dewkoemar Ramsoekh d.ramsoekh@erasmusmc.nl
Hereditary Cancer in Clinical Practice 2009, 7:17 doi:10.1186/1897-4287-7-17
Accesses
- Last 30 days: 93 accesses
- Last 365 days: 1495 accesses
- All time: 4420 accesses